Introduction
Pathomechanisms of gram-negative bacteria in AD
Alteration of gram-negative bacteria in AD
Source | Subject | Method | Gram-negative bacteria | References | |||||
---|---|---|---|---|---|---|---|---|---|
Phylum | Class | Order | Family | Genus | Species | ||||
Feces | APP/PS1 mice | PCR | Proteobacteria | Helicobacteraceae Desulfovibrionaceae | Helicobacter | [33] | |||
Bacteroidetes | Bacteroidia | Bacteroidales | Porphyromonoadaceae | Odoribacter | |||||
PCR | Bacteroidetes | [50] | |||||||
PCR | Bacteroidetes | [32] | |||||||
Bacteroidetes | Bacteroidia | Bacteroidales | Rikenellaceae | ||||||
Bacteroidetes | Bacteroidia | Bacteroidales | S24-7 | ||||||
Verrucomicrobia | Verrucomicrobiae | Verrucomicrobiales | Akkermansiaceae | Akkermansia | |||||
PCR | Bacteroidetes | [34] | |||||||
5×FAD mice | PCR | Proteobacteria | δ-, γ-, ε-Proteobacteria | Helicobacteriaceae, Pseudomonadaceae | [23] | ||||
Bacteroidetes | Bacteroidia | Bacteroidia | Prevotellaceae | ||||||
PCR | Bacteroidetes | [35] | |||||||
PCR | Bacteroidetes | Bacteriodia | Bacteroidales | Muribaculaceae | [10] | ||||
5×FAD mice 3×Tg mice | PCR | Bacteroidetes | [51] | ||||||
Proteobacteria |
Subject | Source | Method | Gram-negative bacteria | References | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Phylum | Class | Order | Family | Genus | Species | |||||
Peripheral system | AD patients | Blood | ELISA | Spirochetes | Spirochetes | Spirochetes | Spirochetaceae | Borrelia | Borrelia burgdorferi | [52] |
Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | |||||
Proteobacteria | Epsilonproteobacteria | Campylobacterales | Helicobacteraceae | Helicobacter | Helicobacter pylori | |||||
WB | Spirochetes | Spirochetes | Spirochetes | Spirochetaceae | Borrelia | Borrelia burgdorferi | [53] | |||
ELISA WB | Spirochetes | Spirochetes | Spirochetes | Spirochetaceae | Borrelia | Borrelia burgdorferi | [46] | |||
Feces | PCR | Firmicutes | Negativicutes | Selenomonadales | Veillonellaceae | Dialister | [9] | |||
Negativicutes | Acidaminococcales | Acidaminococcaceae | Phascolarctobacterium | |||||||
Bacteroidetes | Bacteroidia | Bacteroidales | Bacteroidaceae | Bacteroides | ||||||
Rikenellaceae | Alistipes | |||||||||
Actinobacteria | Actinobacteria | Bifidobacteriales | Bifidobacteriaceae | Bifidobacterium | ||||||
Actinobacteria | Coriobacteriales | Coriobacteriaceae | Adlercreutzia | |||||||
Proteobacteria | Deltaproteobacteria | Desulfovibrionales | Desulfovibrionaceae | Bilophila | ||||||
Central system | AD patients | Brain | PCR EM IEM | Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | [40] |
PCR | Proteobacteria | Gammaproteobacteria | Pseudomonadales | Methylobacteriaceae Moraxellaceae Bradyrhizobiaceae Sphingomonadaceae Comamonadaceae Xanthomonadaceae | [13] | |||||
Bacteroidetes | ||||||||||
PCR | Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | [41] | |||
PCR | Spirochetes | Spirochaetes | Spirochaetes | Spirochaetaceae | Borrelia Treponemas | Borrelia burgdorferi T. pectinovorum T. amylovorum T. lecithinolyticum T. maltophilum, T. medium T. socranski | [42] | |||
PCR | Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | [43] | |||
EM AFM | Spirochetes | [44] | ||||||||
PCR | Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | [45] | |||
IF | Bacteroidetes | Bacteroidia | Bacteroidales | Porphyromonadaceae | Porphyromonas | P. gingivalis | [38] | |||
Spirochetes | Spirochetes | Spirochete | Spirochetaceae | Treponema | T. denticola T. forsythia | |||||
WB | Spirochetes | Spirochetes | Spirochetes | Spirochetaceae | Borrelia | Borrelia burgdorferi | [46] | |||
WB ICC PCR | Proteobacteria | Gammaproteobacteria | Enterobacterales | Enterobacteriaceae | Escherichia coli | [15] | ||||
CSF | PCR | Chlamydia | Chlamydiae | Chlamydiales | Chlamydiaceae | Chlamydophila | Chlamydia pneumoniae | [47] | ||
ELISA | Proteobacteria | Epsilonproteobacteria | Campylobacterales | Helicobacteraceae | Helicobacter | Helicobacter pylori | [48] | |||
Serological analysis ELISA WB | Spirochetes | Spirochetes | Spirochetes | Spirochetaceae | Borrelia | Borrelia burgdorferi | [46] | |||
Histopathologic analysis | Spirochetes | [49] |
Possible roles of gram-negative bacteria in AD pathogenesis
Microbiota dysbiosis
Aβ homeostasis
Gram-negative bacteria-derived products | AD-related pathology | References | |||||
---|---|---|---|---|---|---|---|
Aβ | Tau | Neuroinflammation | Cell death | BBB disruption | |||
In Alzheimer’s disease | Gingipain | Production ↑ | Hyperphosphorylation ↑ Aggregation ↑ | Proinflammatory cytokines ↑ | Pyroptosis ↑ Caspase-1 ↑ | [59] | |
Methylglyoxal (MG) | Production ↑ | Hyperphosphorylation ↑ | Oxidative stress↑ Apoptosis↑ | ||||
Hcp1 | Endothelial cell disruption ↑ | [55] | |||||
Bacterial amyloid | Aggregation ↑ | [82] | |||||
In other diseases | VacA | Proinflammatory cytokines ↑ | Cell vacuolation ↑ | ||||
Bacterial amino-acid | Systemic inflammation ↑ | [10] | |||||
Hcp1 | Endothelial cell disruption ↑ | [55] | |||||
MMP8 | Junctional protein degradation ↑ | [92] | |||||
Phosphorylcholine | Proinflammatory cytokine ↑ | [93] | |||||
Short chain fatty acid | Proinflammatory cytokine ↑ Gliosis ↑ | Endothelial cell disruption ↑ | |||||
Tryptophan | Proinflammatory cytokine ↑ Gliosis ↑ | Endothelial cell disruption ↑ | [97] |
Tau pathology
Neuroinflammation
Neuronal cell death
Specific roles of LPS from gram-negative bacteria in AD
Peripheral and central localization of LPS in AD
Source | Subject | Method | Main findings | References |
---|---|---|---|---|
Brain | AD patients | Immunoblot | LPS was detected in the area adjacent to the lateral ventricle of the parietal lobe of AD brain | [38] |
AD patients | WB IHC | LPS was detected in temporal lobe neocortex perinuclear region of AD brain LPS was co-localized with Aβ plaque | [125] | |
AD patients | IF WB | LPS was detected in superior temporal gyrus gray matter, frontal lobe white matter, and periventricular white matter of AD brain LPS was localized with Aβ plaque, neurons, microglia, and oligodendrocytes | [15] | |
AD patients | IHC | LPS was detected in superior temporal lobe neocortex of AD brain LPS was localized in neurons | [124] | |
AD patients | WB | LPS was detected in temporal lobe neocortex and hippocampus of AD brain | [123] | |
5×FAD mice | IF | LPS was detected in pyramidal and stratum oriens regions of hippocampus of AD brain LPS was co-localized with LPS-phagocytic cell | [23] | |
Blood | AD patients | LAL assay | LPS levels in AD patients were 3- to 6-fold compared with that in control | [22] |
5×FAD mice | ELISA | LPS levels in AD mice were 4-fold compared with that in control | [23] | |
5×FAD mice | LAL assay | LPS levels in AD mice were 4-fold compared with that in control | [136] | |
Feces | 5×FAD mice | LAL assay | LPS levels in AD mice were 3- to 4-fold compared with that in control |
Pathogenic contribution of LPS to AD-related pathology
Aβ homeostasis
Tau pathology
Neuroinflammation
Neurodegeneration
Gram-negative bacteria and their LPS as therapeutic targets in AD
Antibiotics for AD treatment
Therapeutic methods | Treatment or drug | Subject or model | Target (or antibiotic range) | Effects or trial phase | References |
---|---|---|---|---|---|
Antibiotics | Doxycycline | APP/PS1 mice | Gram-positive bacteria Gram-negative bacteria | Cognitive dysfunction↓ Neuroinflammation↓ | [187] |
Gentamicin, Vancomycin, Metronidazole, Neomycin, Ampicillin, Kanamycin, Colistin, and Cefaperazone | APP/PS1 mice | Gram-positive bacteria Gram-negative bacteria | Aβ deposition↓ Soluble Aβ↓ Neuronal loss↓ Gliosis↓ | [188] | |
Rifampicin | AD patients | Gram-positive bacteria Gram-negative bacteria | Phase 2 | NCT03856359 | |
Doxycycline Rifampicin | AD patients | Gram-positive bacteria Gram-negative bacteria | Phase 3 | NCT00439166 | |
Doxycycline Rifampicin | AD patients | Gram-positive bacteria Gram-negative bacteria | Phase 3 | NCT00715858 | |
Minocycline | AD patients | Gram-positive bacteria Gram-negative bacteria | Phase 2 | NCT01463384 | |
Doxycycline Rifampicin | AD patients | Gram-positive bacteria Gram-negative bacteria | Dysfunctional behavior↓ Cognitive dysfunction↓ | [189] | |
Gingipain inhibitor | COR271 COR286 COR388 | BALB/c mice | Gingipain | Aβ deposition↓ TNF-α↓ Neuronal loss↓ | [59] |
COR388 | AD patients | Gingipain | Phase 2/3 | NCT03823404 | |
Probiotics | Lactobacillus acidophilus Bifidobacterium bifidum Bifidobacterium longum | Aβ-administered rats | Intestinal microbiota | Cognitive dysfunction↓ LTP↑ | [190] |
Bifidobacterium longum Lactobacillus acidophilus | APP/PS1 mice | Intestinal microbiota | Cognitive dysfunction↓ Aβ deposition↓ | [191] | |
Lactobacillus plantarum MTCC1325 | D-galactose-induced AD albino rats | Intestinal microbiota | Aβ deposition↓ NFT↓ Cognitive dysfunction↓ Acetylcholine level↑ | [192] | |
Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Lactobacillus fermentum | AD patients | Intestinal microbiota | MMSE score↑ | [193] | |
Lactobacillus casei W56, Lactococcus lactis W19, Lactobacillus acidophilus W22, Bifidobacterium lactis W52, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Bifidobacterium lactis W51, Bifidobacterium bifidum W23, Lactobacillus salivarius W24 | AD patients | Intestinal microbiota | Systemic inflammation↓ | [194] | |
Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum | AD patients | Intestinal microbiota | MMSE score↑ | [195] | |
Lactobacillus fermentum, Lactobacillus plantarum, Bifidobacterium lactis Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum | AD patients | Intestinal microbiota | Cognitive dysfunction- | [196] | |
Intestinal microbiota reconstruction | Mediterranean-style diet | MCI patients | Non-specific bacteria | Changes of the microbiota | [157] |
Mediterranean-style diet | MCI patients | Non-specific bacteria | Changes of the microbiota | [197] | |
Curcumin | APP/PS1 mice | Non-specific bacteria | Cognitive impairment↓ Aβ deposition↓ Changes of the microbiota | [198] | |
Folate and vitamin B-12 | Aβ-administered rats | Non-specific bacteria | Changes of the microbiota | [199] | |
Ginsenoside Rg1 | Tree shrew model of AD | Non-specific bacteria | Aβ deposition↓ Phosphorylated tau↓ Pro-apoptotic factor↓ Changes of the microbiota | [200] | |
Streptococcus thermophilus, Bifidobacteria longum, Bifidobacteria breve, Bifidobacteria infantis, Lactobacillus acidophilus, Lactobacillus plantarum,Lactobacillus paracasei, Lactobacillus delbrueckii subsp, Bulgaricus, Lactobacillus brevis | 3xTg mice | Intestinal microbiota | Cognitive impairment↓ Aβ deposition↓ Neuronal loss↓ | [201] | |
NK46 (Bifidobacterium longum) oral administration | 5xFAD mice | Gram-negative bacteria | Pro-inflammatory cytokines↓ LPS↓ Gliosis↓ Neuronal loss↓ Aβ↓ Cognitive dysfunction↓ | [23] | |
Fecal microbiota transplant | ADLPAPT mice | Microbiota dysbiosis | Aβ deposition↓ NFT↓ Neuroinflammation↓ Cognitive dysfunction↓ | [202] | |
Fecal microbiota transplant | AD patients | Microbiota dysbiosis | MMSE score↑ | [203] | |
Fecal microbiota transplant | AD patients | Microbiota dysbiosis | Phase 1 | NCT03998423 |